Garlic peel-based carbon quantum dots as a sustainable alternative for the sensitive and green spectrofluorometric quantification of molnupiravir in pharmaceutical capsules

Searching for natural alternatives to replace environmentally harmful chemical reagents in analysis is just as crucial as finding easily accessible analytical tools. To reinforce these concepts, this study proposes a simple spectrofluorometric approach using natural carbon quantum dots (n-CQDs) as f...

Full description

Bibliographic Details
Published in:	Heliyon
Main Authors:	Yomna A. Saber, Mahmoud Hamed, Samy Emara, Fotouh R. Mansour, Marcello Locatelli, Noha Ibrahim
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Subjects:	Molnupiravir Garlic peels Natural carbon quantum dots n-CQDs Spectrofluorometry
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024166923

Similar Items

Indirect Spectrofluorometric Determination of Enoxaparin Sodium in Pharmaceutical Formulation (Injection) by Ion Association Complex Formation with Acriflavine Dye
by: mohamed aghwan, et al.
Published: (2020-06-01)

A synchronous spectrofluorometric technique for simultaneous detection of alfuzosin and tadalafil: applied to tablets and spiked biological samples
by: Heba Samir Elama, et al.
Published: (2022-07-01)

Simultaneous spectrofluorometric analysis of tablets containing hydrochlorothiazide combined with timolol maleate or amiloride hydrochloride
by: Wedian Fadel, et al.
Published: (2020-09-01)

Evaluation of Pretreatments and Extraction Conditions on the Antifungal and Antioxidant Effects of Garlic (<i>Allium sativum</i>) Peel Extracts
by: David Fernando Carreón-Delgado, et al.
Published: (2023-01-01)

Preliminary Study on Fe(III) Detection Using Nitrogen-Doped Carbon Quantum Dots via HSV-Based Smartphone Fluorescence Analysis
by: Erika Agustina, et al.
Published: (2025-09-01)

Evaluation of Onion Peel as Feed Additive on Performance Production Broiler
by: Saadatin Nurul Jannah, et al.
Published: (2024-07-01)

Valorization of the phytochemical profile, nutritional composition, and therapeutic potentials of garlic peel: a concurrent review
by: Faiza Azmat, et al.
Published: (2023-09-01)

Garlic (Allium sativum L.) peel extracts: From industrial by-product to food additive
by: Paula Correia Medeiros dos Santos, et al.
Published: (2022-12-01)

Safety and Effectiveness of Molnupiravir (LAGEVRIO®) Capsules in Japanese Patients with COVID-19: Interim Report of Post-marketing Surveillance in Japan
by: Masahiro Kimata, et al.
Published: (2023-03-01)

Garlic Peel-Based Biochar Prepared under Weak Carbonation Conditions for Efficient Removal of Methylene Blue from Wastewater
by: Tao-Tao Shi, et al.
Published: (2024-10-01)

Green valorization of garlic peel waste using halophilic laccase for efficient biomass delignification and biorefinery applications
by: Tina Adelpour, et al.
Published: (2025-05-01)

DETERMINATION OF METOPROLOL IN PURE AND PHARMACEUTICAL DOSAGE FORMS BY SPECTROFLUOROMETRY AND HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
by: BILAL YILMAZ, et al.
Published: (2011-03-01)

Phase I Pharmacokinetics Study of Oral Administration of Esperavir® (INN: Molnupiravir) (LLC "PROMOMED RUS", Russia)
by: T. N. Komarov, et al.
Published: (2024-03-01)

BIOEQUIVALENCE STUDY OF GENERIC MOLNUPIRAVIR IN HEALTHY VOLUNTEERS
by: V. B. Vasilyuk, et al.
Published: (2023-02-01)

Molnupiravir as an Early Treatment for COVID-19: A Real Life Study
by: Michela Pontolillo, et al.
Published: (2022-09-01)

Can Tremor Be a Rare Side Effect Related to Molnupiravir?
by: Sinan MERMER, et al.
Published: (2022-11-01)

Effect of Feeding Pomegranate (<i>Punica granatum</i>) Peel and Garlic (<i>Allium sativum</i>) on Antioxidant Status and Reproductive Efficiency of Female Rabbits
by: Omnia Y. Abd-Elfadiel Hagag, et al.
Published: (2023-02-01)

Efficacy and safety of molnupiravir in adult outpatients with COVID-19
by: Natalia Y. Pshenichnaya, et al.
Published: (2023-06-01)

Degree-Based and Neighborhood Degree Sum-Based Entropy Measures of Molnupiravir
by: Shibsankar Das, et al.
Published: (2025-06-01)

Determination of human growth hormone in pure and pharmaceutical dosage form by spectrofluorometry and high performance liquid chromatography
by: Yilmaz Bilal, et al.
Published: (2012-01-01)

Antiviral Efficacy of Molnupiravir for COVID-19 Treatment
by: Yuan Bai, et al.
Published: (2022-04-01)

Reciprocal Impact of Molnupiravir and Favipiravir Monocomponents of the Combination Drug on Each Other's Pharmacokinetics in a Phase I Clinical Trial
by: T. N. Komarov, et al.
Published: (2024-03-01)

Molnupiravir and Its Active Form, EIDD-1931, Show Potent Antiviral Activity against Enterovirus Infections In Vitro and In Vivo
by: Yuexiang Li, et al.
Published: (2022-05-01)

Molnupiravir Inhibits Porcine Epidemic Diarrhea Virus Infection In Vitro
by: Zi-Xin Huang, et al.
Published: (2023-06-01)

Real-World Utilization of Molnupiravir during the COVID-19 Omicron Surge in Israel
by: Clara Weil, et al.
Published: (2023-08-01)

Interaction between warfarin and molnupiravir in a patient with coronavirus disease 2019 infection
by: Hikari Mizutani, et al.
Published: (2022-01-01)

A Green Voltammetric Determination of Molnupiravir Using a Disposable Screen-Printed Reduced Graphene Oxide Electrode: Application for Pharmaceutical Dosage and Biological Fluid Forms
by: Abdelrahman Nabil, et al.
Published: (2023-08-01)

Garlic Peel-Derived Phytochemicals Using GC-MS: Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Effects in Ulcerative Colitis Rat Model
by: Duaa A. Althumairy, et al.
Published: (2025-06-01)

Molnupiravir: From Hope to Epic Fail?
by: Daniele Focosi
Published: (2022-11-01)

Full factorial design assisted RP-UHPLC method development and study of stressed degradation of molnupiravir
by: Omar Faruk, et al.
Published: (2024-01-01)

Molnupiravir's real-world effectiveness in COVID-19 outpatients at high risk of severe disease: a single-center study
by: Ivana I Gmizic, et al.
Published: (2024-05-01)

GS-441524 and molnupiravir are similarly effective for the treatment of cats with feline infectious peritonitis
by: Okihiro Sase, et al.
Published: (2024-07-01)

Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity
by: Ashley Jia Wen Yip, et al.
Published: (2022-06-01)

Short- and long-term comparative effectiveness of nirmatrelvir/ritonavir and molnupiravir in asthma patients: a cohort study
by: Guozhang Lin, et al.
Published: (2025-02-01)

Molnupiravir and Nirmatrelvir/Ritonavir: The New Available Antiviral Options for COVID-19
by: Samuel Theodorus Sutanto, et al.
Published: (2022-12-01)

Respiratory virus coinfections during the COVID-19 pandemic: epidemiologic analysis and clinical outcomes from the Phase 2/3 molnupiravir trial (MOVe-OUT)
by: Matthew G. Johnson, et al.
Published: (2024-03-01)

Molnupiravir and Nirmatrelvir/Ritonavir: The New Available Antiviral Options for COVID-19
by: Samuel Theodorus Sutanto, et al.
Published: (2023-01-01)

Molnupiravir Revisited—Critical Assessment of Studies in Animal Models of COVID-19
by: Henrik Berg Rasmussen, et al.
Published: (2023-10-01)

THE EFFECT OF RED AND YELLOW CARBON QUANTUM DOTS (CQDS) IN TIO2 PHOTOANODES FOR DSSC APPLICATION
by: Farhan Nur Al-Afandy, et al.
Published: (2025-04-01)

Molnupiravir for the treatment of COVID-19 outpatients: An updated meta-analysis
by: Huzaifa Ahmad Cheema, et al.
Published: (2024-06-01)